DIGESTIVE AND LIVER DISEASE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2021-08-24 12213dcbm39暂无昵称

审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0
偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病
经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。

0 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2022-06-06 ms1000000947456498

偏重的研究方向：基础研究
经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业

66 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2020-10-18 1248756em59(暂无昵称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。

178 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2022-05-18 148ba275m67暂无昵称

我也是想请教大家，怎么一直在初始投稿状态

61 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2022-11-03 RamonaHWW

请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？

112 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2022-04-27 282597582

偏重的研究方向：肝细胞癌;临床研究
经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么

61 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2021-06-03 147a5f5cm41(暂无昵称)

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：消化
经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的

68 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2023-08-21 左手摸机来自浙江省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！

42 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2023-11-04 ms4000002096191420 来自广西

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月

27 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010931, encodeId=1736101093195, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:3300.0 偏重的研究方向：消化系统良性疾病;急性胰腺炎;肝病 经验分享：最近接收一篇，7月13投稿，8.3第一次返修，8.14第二次返修，8.20接收。这个杂志效率很高。以前全部都不收版面费，现在可选择OA付版面费3300美刀或者不交版面费（但是得接收后1年才能online）。投稿后一直是初始的时间状态不会显示under review，如果一个礼拜没拒稿基本就是送审了，耐心等待即可。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=12213dcbm39暂无昵称, createdTime=Tue Aug 24 11:35:45 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224667, encodeId=9bb1122466e19, content=偏重的研究方向：基础研究 经验分享：5月5日投稿，5月15日under review，今天6月6日也还没有消息，好急呀，赶着明年毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1676564630, createdName=ms1000000947456498, createdTime=Mon Jun 06 08:02:30 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220580, encodeId=335a12205808f, content=我也是想请教大家，怎么一直在初始投稿状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=889e5325563, createdName=148ba275m67暂无昵称, createdTime=Wed May 18 00:25:23 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215059, encodeId=2d071215059a6, content=偏重的研究方向：肝细胞癌;临床研究 经验分享：24号投稿，26号分配的稿件号，500➕，不知道多久能送审？有知道的小伙伴们么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Wed Apr 27 16:37:43 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970706, encodeId=76e99e0706a8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：消化 经验分享：一篇回顾性内镜相关研究投了将近3个月两次小修，编辑和审稿人都比较负责提了很多有用的意见，编辑会逐个字地看，会将一些discussion表达不到位的叫你修改而且免费，除了时间长了一点，这个杂志还是挺不错的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Thu Jun 03 22:47:46 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：消化系统良性疾病 经验分享：5.19 投，5.22 拒，没有写理由，很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京)]

2023-05-24 ms6000001767911714 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：消化系统良性疾病
经验分享：5.19 投，5.22 拒，没有写理由，很伤心

48 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务